Haitai Bio Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

Haitai Bio General Information

Description

Developer of animal vaccines designed for aquaculture and animal husbandry industry. The company develops vaccines, therapeutic proteins, and diagnostic solutions through proprietary technologies such as epitope-targeted binding proteins and reverse encapsulation methods, enabling the aquaculture and livestock markets to improve disease resistance, reduce mortality rates, enhance productivity, and maintain sustainable farming practices

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 101, Building K, Number 188 Linjiang Avenue, Linjiang Town
  • Haimen District
  • Nantong, Jiangsu 226000
  • China
+86 020
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Commercial Products
Vertical(s)
Manufacturing, AgTech
Corporate Office
  • Room 101, Building K, Number 188 Linjiang Avenue, Linjiang Town
  • Haimen District
  • Nantong, Jiangsu 226000
  • China
+86 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Haitai Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 31-Mar-2025 Completed Generating Revenue
2. Later Stage VC (Series A) 08-Dec-2022 Completed Generating Revenue
1. Seed Round 20-Mar-2018 Completed Startup
To view Haitai Bio’s complete valuation and funding history, request access »

Haitai Bio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Jiangsu Dongbuzhou Venture Capital Growth/Expansion Minority
Jiangsu Xinzhi Equity Investment Management Venture Capital Minority
Nantong Science and Technology Innovation Investment Group Government Minority
Timesbole Venture Capital Minority
Nantong Blue Bay Venture Capital Management Growth/Expansion Minority
To view Haitai Bio’s complete investors history, request access »

Ready to get started?

Request a free trial

Haitai Bio FAQs

  • When was Haitai Bio founded?

    Haitai Bio was founded in 2017.

  • Where is Haitai Bio headquartered?

    Haitai Bio is headquartered in Nantong, China.

  • What industry is Haitai Bio in?

    Haitai Bio’s primary industry is Drug Discovery.

  • Is Haitai Bio a private or public company?

    Haitai Bio is a Private company.

  • What is Haitai Bio’s current revenue?

    The current revenue for Haitai Bio is .

  • Who are Haitai Bio’s investors?

    Jiangsu Dongbuzhou Venture Capital, Jiangsu Xinzhi Equity Investment Management, Nantong Science and Technology Innovation Investment Group, Timesbole, and Nantong Blue Bay Venture Capital Management have invested in Haitai Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process